Skip to content
Application 212725
- Type
- NDA
- Sponsor
- GENENTECH INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ROZLYTREK | ENTRECTINIB | CAPSULE;ORAL | 100MG | Yes | No |
| 002 | ROZLYTREK | ENTRECTINIB | CAPSULE;ORAL | 200MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50242-091 | Rozlytrek | ENTRECTINIB | Genentech, Inc. | NDA | Current |
| 50242-091 | Rozlytrek | ENTRECTINIB | Genentech Inc. | NDA | Current |
| 50242-091 | Rozlytrek | ENTRECTINIB | Genentech, Inc. | NDA | Current |
| 50242-091 | Rozlytrek | ENTRECTINIB | Genentech, Inc. | NDA | Current |
| 50242-091 | Rozlytrek | ENTRECTINIB | Genentech Inc. | NDA | Current |
| 50242-091 | Rozlytrek | ENTRECTINIB | Genentech Inc. | NDA | Current |
| 50242-091 | Rozlytrek | ENTRECTINIB | Genentech Inc. | NDA | Current |
| 50242-094 | Rozlytrek | ENTRECTINIB | Genentech, Inc. | NDA | Current |
| 50242-094 | Rozlytrek | ENTRECTINIB | Genentech Inc. | NDA | Current |
| 50242-094 | Rozlytrek | ENTRECTINIB | Genentech, Inc. | NDA | Current |
| 50242-094 | Rozlytrek | ENTRECTINIB | Genentech, Inc. | NDA | Current |
| 50242-094 | Rozlytrek | ENTRECTINIB | Genentech Inc. | NDA | Current |
| 50242-094 | Rozlytrek | ENTRECTINIB | Genentech Inc. | NDA | Current |
| 50242-094 | Rozlytrek | ENTRECTINIB | Genentech Inc. | NDA | Current |